Efficacy and Safety of the Combination Therapy Based on Eravacycline in Immunocompromised Hosts With MDROS Infection
Clinical trial NCT06223100 · UNKNOWN
Trial details
- NCT number
- NCT06223100
- Sponsor
- Sichuan Provincial People's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.